- Home
- HRTX vs ABSI Comparison
HRTX vs ABSI Comparison
Compare HRTX & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- ABSI
- Stock Information
- Founded
- HRTX 1983
- ABSI 2011
- Country
- HRTX United States
- ABSI United States
- Employees
- HRTX N/A
- ABSI N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- HRTX Health Care
- ABSI Health Care
- Exchange
- HRTX Nasdaq
- ABSI Nasdaq
- Market Cap
- HRTX 325.0M
- ABSI 353.8M
- IPO Year
- HRTX 1987
- ABSI 2021
- Fundamental
- Price
- HRTX $1.93
- ABSI $2.71
- Analyst Decision
- HRTX Strong Buy
- ABSI Strong Buy
- Analyst Count
- HRTX 2
- ABSI 5
- Target Price
- HRTX $5.50
- ABSI $8.40
- AVG Volume (30 Days)
- HRTX 2.1M
- ABSI 2.9M
- Earning Date
- HRTX 05-06-2025
- ABSI 05-13-2025
- Dividend Yield
- HRTX N/A
- ABSI N/A
- EPS Growth
- HRTX N/A
- ABSI N/A
- EPS
- HRTX N/A
- ABSI N/A
- Revenue
- HRTX $148,518,000.00
- ABSI $4,815,000.00
- Revenue This Year
- HRTX $12.60
- ABSI $145.79
- Revenue Next Year
- HRTX $13.66
- ABSI $99.29
- P/E Ratio
- HRTX N/A
- ABSI N/A
- Revenue Growth
- HRTX 12.43
- ABSI N/A
- 52 Week Low
- HRTX $1.04
- ABSI $2.01
- 52 Week High
- HRTX $3.93
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- HRTX 45.93
- ABSI 41.72
- Support Level
- HRTX $1.82
- ABSI $2.59
- Resistance Level
- HRTX $1.93
- ABSI $2.84
- Average True Range (ATR)
- HRTX 0.11
- ABSI 0.20
- MACD
- HRTX -0.00
- ABSI -0.01
- Stochastic Oscillator
- HRTX 56.76
- ABSI 10.09
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.